EDITORIAL: Is the Beneficial Effect of Mediterranean Diet on Cardiovascular Risk Partly Mediated through Better Blood Pressure Control?
The Open Hypertension Journal · 2013
DOI: 10.2174/1876526201305010036 ↗Abstract
A few days ago, in August 2013, a Cochrane Database Systemic Review reported that the existing limited evidence to date on the effect of Mediterranean diet (MD) on primary prevention of cardiovascular disease (CVD), suggests some favorable effects on risk factors; however, the reduction of CVD event rates was not mentioned [1]. The review included 11 trials (15 papers, 52,044 participants); 7 trials described the intervention as a MD. Clinical events were reported in only one trial [Women's Health Initiative (WHI) 48,835 postmenopausal women with an intervention not described as a MD but increased fruit and vegetable and cereal intake], where no statistically significant effects of the intervention were seen on fatal and non-fatal endpoints during the 8 years of its duration [1]. Since the WHI study was huge and had a great weight in the analysis, it eliminated any other beneficial effect on CVD incidence from other studies. Moreover, in this study the diet used as an intervention was not MD. On April 2013 the results of the Prevención con Dieta Mediterránea (PREDIMED), a multicenter trial from Spain, were published in New England Journal of Medicine [2]. The study included a total of 7,447 persons (aged 55-80 years) with no CVD at baseline. These were randomized to 1 of 3 diets: a MD supplemented with extra-virgin olive oil, a MD supplemented with mixed nuts or a control diet (advice to reduce dietary fat) [2]. An interim analysis terminated the trial prematurely at 4.8 years. The primary endpoint was the rate of major CVD (myocardial infarction, stroke, or CVD death). The multivariable-adjusted hazard ratios were 0.70 (95% confidence interval [CI], 0.54 to 0.92) and 0.72 (95% CI, 0.54 to 0.96) for the group assigned to a MD with extravirgin olive oil and the group assigned to a MD with nuts, respectively, vs. the control group [2]. No diet-related adverse effects were reported [2]. Moreover, a post hoc analysis of PREDIMED that will be published in September 2013, in the American Journal of Clinical Nutrition, suggests that one of the mechanisms by which MD, particularly if supplemented with virgin olive oil, can exert health benefits is through changes in the transcriptomic response of genes related to CVD risk [3]. These results of the PREDIMED trial confirm that changes in diet can have beneficial effects on CVD risk. However, the study was criticized for mainly 3 reasons. One is that in MD the dietary pattern as an entity is rather more important than the inclusion or avoidance of specific nutrients [4]. Second there were low (in absolute terms) primary composite CVD outcome rates (3.8% and 3.4% in the intervention groups vs. 4.4% in the control group) and a minor absolute risk difference (range 0.6 to 1%), thus limiting the importance of the study findings [5]. Furthermore there were statistically significant differences in baseline characteristics between the groups: men (+5.7%), obese persons (+4.7%), diuretic use (+3.5%), and oral hypoglycaemic use (+3.2%) in the control group than in the intervention group [5]. And third there was a complete lack of policy implications [6]. The PREDIMED trial was neither a pure test of a Mediterranean-style diet nor a pure test of extra- virgin olive oil or nuts. All the above make the interpretation of the PREDIMED trial similarly difficult to that of the Lyon Diet Heart Study [7], which tested provision of a margarine rich in alpha-linolenic acid on top of brief advice to consume a MD in high CVD risk patients with astonishing results [7]. Policymakers [8] and Great Scientific Organizations, like Mayo Clinic [9], already recommend consumption of a Mediterranean-style diet on the basis of a body of evidence from observational and interventional studies, in antithesis to the findings of the Cochrane Database Systemic Review [1]. On the other hand, the policy implications of the PREDIMED trial related primarily to the supplemental foods [2] and not MD itself, thus, we probably have to go both back and elsewhere to find evidence base for the benefits of MD and if these are related in any degree to blood pressure (BP) reduction. The Seven Countries Study showed that the risk and rates of heart attack and stroke both at the population and at the individual level were directly and independently related to the level of serum total cholesterol (TC). It demonstrated that the association between TC level and coronary heart disease (CHD) risk from 5 to 40 years follow-up is found consistently across different cultures [10,11]. The Seven Countries Study started in 1958 in former Yugoslavia. In total, 12,763 men, 40–59 years of age, were enrolled as 16 cohorts, in 7 countries, in 4 regions of the world (United States, Northern Europe, Southern Europe, Japan); 1 cohort is in the United States, 2 cohorts in Finland, 1 in the Netherlands, 3 in Italy, 5 in the former Yugoslavia (two in Croatia, and three in Serbia), 2 in Greece (1 in Crete and 1 in Corfu), and 2 in Japan [10]. The Seven Countries Study has continued, with high levels of participation, for more than 50 years.The initial and objective data on CVD health in relation to the MD originated from the Seven Countries Study [10]. CHD deaths in the United States and Northern Europe greatly exceeded those in Southern Europe, even when controlled for age, TC and BP levels, smoking, physical activity, and weight [12]. After further investigation, the importance of the eating pattern characterized as the MD became clear [12,13]. What exactly is meant by "Mediterranean diet" today, and its benefits, is detailed by other researches during the last 20 years [14,15]. During the 90's, for the first time, the concept of a food pyramid and the need for an adherence to MD score were born [14-16]. As a result of the Seven Countries Study, the MD has been popularized as a "healthy" diet. Nevertheless, it has not replaced the "prudent" diet commonly prescribed to coronary patients [17]. The Crete cohort of the Seven Countries Study had the lowest rates of deaths from CVD [10]; even the 25 year mortality was lower than others (for example vs. the Italian cohort) [18]. This was attributed to the entire lifestyle of Cretans including a variation of MD, the Cretan-type MD. Many investigators during the last 20 years would rather refer to the Cretan-type MD rather than plain MD, which is a rather abstract definition [19-22]. The 40 years’ CVD mortality in the Corfu cohort showed that participants also benefited from the long-term adoption of a nutritional pattern (close to the Cretan-type) of MD, the presence of physical activity, optimism, and a positive psychological profile [23]. During the last 15 years, and before the economic crisis, Greeks adopted a more western way of life. Nevertheless, several aspects of the traditional Greek way of life and diet, suggest that a relatively high consumption of vegetables and fruits or olive oil and bread, remained well-established among large segments of the Greek population, and may explain why a population with a few healthy habits still enjoys one of the longer life expectancies among the 16 cohorts of the Seven Country Study 40 years after its initiation [23]. The Working Group on Epidemiology and Prevention of the European Society of Cardiology (ESC) coordinated in 2003 information from 12 European cohort studies, including 205,000 persons, and assessed the 10-year CVD mortality rates. This gave birth to the SCORE (Systematic Coronary Risk Estimation) project [24]. The European Society of Cardiology encouraged the creation of local SCORES for each country, based on the original SCORE and local data. Indeed the HellenicSCORE (equations and charts) present the calibration of the risk by age group and sex, based on mortality data, as reported by the National Statistical Services of Greece and prevalence data regarding smoking, TC and BP levels, as reported by the ATTICA study [25]. This was very successfully tested in the ATTEMPT Study [26]. The predicated rates of CVD were verified in a survival study with a nearly 4-year follow-up in patients with metabolic syndrome and randomization to intensive versus moderate risk factor treatment [27]. In the meantime the MD score (MedDietScore) was developed, according to the adherence to MD [28].The weekly consumption of the following 9 food groups: non-refined cereals(whole grain bread and pasta, brown rice, etc.), fruits, vegetables, legumes, potatoes, fish, meat and meat products, poultry, full fat dairy products (like cheese, yoghurt, milk), as well asolibe oil and alcohol intake, were included [28]. The inclusion of dietary evaluation (MedDietScore), as well as other sociodemographic and anthropometric characteristics, increases the accuracy and reduces estimating bias of CVD risk prediction models [29]. Thus, we have a country adjusted integrated system that can predict CVD risk. It was clear, during the use of HellenicSCORE and MedDietScore, that a better adherence to MD was related to a lower CVD risk. On the contrary, aging, central fat, hypertension (HTN), diabetes, inflammation, low social status and abstinence from a MD seem to predict CVD events within a 5-year period; actual data from the ATTICA study [30]. All these put the adoption of MD at a high position among CVD risk factors, for good and for bad, according to the degree of adoption (MedDietScore). However, does MD affect the level of BP? Is HTN one of the factors to increase CVD risk if the adherence to MD (MedDietScore) is low? There is some evidence on this issue. It has been suggested by a review on the dietary influences on BP that there is more than enough evidence from observational and clinical studies that diets low in saturated fats and sodium and rich in fruits, vegetables, and fiber, with adequate amounts of potassium, calcium, and magnesium, are effective in the prevention and treatment of HTN alone or as an adjunct to pharmacologic therapy [31]. Such dietary combinations are provided by the MD [31]. The association of adherence to the MD with the incidence of HTN was evaluated among 9,408 men and women enrolled in a dynamic Spanish prospective cohort (SUN) study during 1999- 2005 [32]. The adherence to MD was associated with reduced mean values of systolic BP [moderate adherence, -2.4 mm Hg (95% CI: -4.0, -0.8); high adherence, -3.1 mm Hg (95% CI: -5.4, -0.8)] and diastolic BP [moderate adherence, - 1.3 mm Hg (95% CI: -2.5, -0.1); high adherence, -1.9 mm Hg (95% CI: -3.6, -0.1)] after 6 years of follow-up [32]. These results suggest that adhering to a Mediterranean-type diet could contribute to the prevention of age-related increase in BP [32]. In the ATTICA Study the mean value of the MedDiet Score was 25.5 (±3) for men and 27 (±3) for women (p
EUVIMED